Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2358493
Max Phase: Preclinical
Molecular Formula: C30H38ClN3O5
Molecular Weight: 556.10
Molecule Type: Small molecule
Associated Items:
ID: ALA2358493
Max Phase: Preclinical
Molecular Formula: C30H38ClN3O5
Molecular Weight: 556.10
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN([C@H](C)CO)C(=O)c2cc(NC(=O)C3CCCCC3)ccc2O[C@H]1CN(C)C(=O)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C30H38ClN3O5/c1-19-16-34(20(2)18-35)30(38)25-15-24(32-28(36)21-7-5-4-6-8-21)13-14-26(25)39-27(19)17-33(3)29(37)22-9-11-23(31)12-10-22/h9-15,19-21,27,35H,4-8,16-18H2,1-3H3,(H,32,36)/t19-,20-,27+/m1/s1
Standard InChI Key: KOSHVSUTRJPFSQ-DVHCVUMVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 556.10 | Molecular Weight (Monoisotopic): 555.2500 | AlogP: 4.85 | #Rotatable Bonds: 7 |
Polar Surface Area: 99.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.32 | CX LogD: 4.32 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.51 | Np Likeness Score: -0.94 |
1. PubChem BioAssay data set, |
2. Dockendorff C, Faloon PW, Pu J, Yu M, Johnston S, Bennion M, Penman M, Nieland TJ, Dandapani S, Perez JR, Munoz B, Palmer MA, Schreiber SL, Krieger M.. (2015) Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake., 25 (10): [PMID:25900219] [10.1016/j.bmcl.2015.03.073] |
Source(2):